Synthesis and distribution of CARDS toxin during mycoplasma pneumoniae infection in a murine model

Journal of Infectious Diseases

Volumn 204, Issue 10, 2011, Pages 1596-1604

  Kannan, T R ^a   Coalson, Jacqueline J ^b   Cagle, Marianna ^a   Musatovova, Oxana ^a   Hardy, R Doug ^c,d   Baseman, Joel B ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ID Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADHESIN; BACTERIAL TOXIN; COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; LUNG LAVAGE; LYMPHOCYTE COUNT; MOUSE; MYCOPLASMA PNEUMONIA; NEUTROPHIL COUNT; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; SEROCONVERSION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE; MICE, INBRED BALB C; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 80054747874     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir557     Document Type: Article

References (50)

1. Baseman JB, Reddy SP, Dallo SF. Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 1996; 154:S137-44. (Pubitemid 26346897)
2. Baseman JB, Tully JG. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997; 3:21-32. (Pubitemid 127433636)
3. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17:697-728. (Pubitemid 39372513)
4. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998; 158:998-1001. (Pubitemid 28449473)
5. Nisar N, Guleria R, Kumar S, Chand Chawla T, Ranjan Biswas N. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007; 83:100-4. (Pubitemid 46340337)
6. Seggev JS, Lis I, Siman-Tov R, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 1986; 57:263-5. (Pubitemid 16008807)
7. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest 2007; 132:1962-6.
8. Yano T, Ichikawa Y, Komatu S, Arai S. Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 1994; 149:1348-53. (Pubitemid 24147080)
9. Berg CP, Kannan TR, Klein R, et al. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int 2009; 29:797-809.
10. Talkington DF, Waites KB, Schwartz SB, Besser RE. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections. In: ScheldWM, CraigWA,Hughes JM, eds. Emerging infections 5. Washington, DC: American Society for Microbiology, 2001; 57-84.
11. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993; 70:23-5. (Pubitemid 23042030)
12. Collier AM, Clyde WA, Jr, Denny FW. Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture. Proc Soc Exp Biol Med 1969; 132:1153-8.
13. Hu PC, Collier AM, Baseman JB. Interaction of virulent Mycoplasma pneumoniae with hamster tracheal organ cultures. Infect Immun 1976; 14:217-24.
14. Murphy GF, Brody AR, Craighead JE. Exfoliation of respiratory epithelium in hamster tracheal organ cultures infected with Mycoplasma pneumoniae. Virchows Arch A Pathol Anat Histol 1980; 389:93-102. (Pubitemid 11251419)
15. Woodruff KH, Schneider E, Unger L. Coalson JJ. Ultrastructural changes in hamster tracheal ring cultures exposed to Mycoplasma pneumoniae. Am J Pathol 1973; 72:91-102.
16. Balasubramanian S, Kannan TR, Baseman JB. The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect Immun 2008; 76:3116-23.
17. Baseman JB, Banai M, Kahane I. Sialic acid residues mediate Mycoplasma pneumoniae attachment to human and sheep erythrocytes. Infect Immun 1982; 38:389-91.
18. Baseman JB, Cole RM, Krause DC, Leith DK. Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol 1982; 151: 1514-22. (Pubitemid 13230856)
19. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 2002; 46:1041-51. (Pubitemid 35370592)
20. Kannan TR, Provenzano D, Wright JR, Baseman JB. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun 2005; 73:2828-34. (Pubitemid 40570350)
21. Hu PC, Collier AM, Baseman JB. Alterations in the metabolism of hamster tracheas in organ culture after infection by virulent Mycoplasma pneumoniae. Infect Immun 1975; 11:704-10.
22. Hardy RD, Jafri HS, Olsen K, et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: A microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 2001; 69:3869-76. (Pubitemid 32493307)
23. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24:577-82. (Pubitemid 32442765)
24. Hardy RD, Jafri HS, Olsen K, et al. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: A murine model of infection-associated chronic reactive airway disease. Infect Immun 2002; 70:649-54. (Pubitemid 34083823)
25. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ. Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003; 71:1520-6. (Pubitemid 36254340)
26. Fonseca-Aten M, Rios AM, Mejias A, et al. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. Am J Respir Cell Mol Biol 2005; 32:201-10. (Pubitemid 40387646)
27. Leith DK, Trevino LB, Tully JG, Senterfit LB, Baseman JB. Host discrimination of Mycoplasma pneumoniae proteinaceous immunogens. J Exp Med 1983; 157:502-14. (Pubitemid 13145055)
28. Powell DA, Hu PC, Wilson M, Collier AM, Baseman JB. Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect Immun 1976; 13:959-66.
29. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A 2006; 103:6724-9.
30. Kannan TR, Musatovova O, Balasubramanian S, et al. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol Microbiol 2010; 76:1127-41.
31. Cimolai N, Taylor GP, Mah D. Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol 1992; 36:465-78.
32. Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods 2000; 41:45-51. (Pubitemid 30345719)
33. Dallo SF, Su CJ, Horton JR, Baseman JB. Identification of P1 gene domain containing epitope(s) mediating Mycoplasma pneumoniae cytoadherence. J Exp Med 1988; 167:718-23. (Pubitemid 18073673)
34. Techasaensiri C, Tagliabue C, Cagle M, et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med 2010; 182:797-804.
35. Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 2009; 4:e7562.
36. Rollins S, Colby T. Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med 1986; 110:34-41. (Pubitemid 16011808)
37. Posati LA, Leslie KO. Lung infections. In: Leslie KO, Wick MR, eds. Practical pulmonary pathology. A diagnostic approach. Philadelphia, PA: Churchill Livingstone, 2005; 97-180.
38. Biberfeld G, Norberg R. Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol 1974; 112:413-5.
39. Ruuth E, Praz F. Interactions between mycoplasmas and the immune system. Immunol Rev 1989; 112:133-60.
40. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 1995; 162:133-42.
41. Opitz O, Pietsch K, Ehlers S, Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: The role of T cell subsets in aggravating the inflammatory response. Immunobiology 1996; 196:575-87. (Pubitemid 27168449)
42. Llibre JM, Urban A, Garcia E, Carrasco MA, Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin Infect Dis 1997; 25:1340-2. (Pubitemid 28022667)
43. Wang L,Hong KC, Lin FC, Yang KD. Mycoplasma pneumoniae-associated Stevens-Johnson syndrome exhibits lymphopenia and redistribution of CD41 T cells. J Formos Med Assoc 2003; 102:55-8. (Pubitemid 36656423)
44. Denny FW, Clyde WA, Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 1971; 123:74-92.
45. Foy HM, Grayston JT, Kenny GE, Alexander ER, McMahan R. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966; 197:859-66.
46. Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 2008; 8:93.
47. Smith CB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 1967; 276:1172-5.
48. Peters J, Singh H, Brooks EG, et al. Persistence of Community Acquired Respiratory Distress Syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 2011; 140:401-7.
49. Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 2000; 29:301-9.
50. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: A role in asthma pathogenesis? Am J Respir Crit Care Med 2005; 172:1078-89. (Pubitemid 43066642)